公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2001 | Probable reinfection with hepatitis C virus in a chronic hepatitis C patient with a sustained response to combination therapy | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 9 | 9 | |
2014 | A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: A prospective study with propensity score matching analysis | Huang T.-S.; Huang S.-S.; Shyu Y.-C.; Lee C.-H.; Jwo S.-C.; PEI-JER CHEN ; Chen H.-Y. | PLoS ONE | 21 | 20 | |
1991 | Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line | Wu J.-C.; PEI-JER CHEN ; YEN-PING KUO ; Lee S.-D.; DING-SHINN CHEN ; Ting L.-P. | Journal of Virology | 128 | 123 | |
2019 | Profile and value of FIB-4 in patients with dual chronic hepatitis C and B | CHUN-JEN LIU ; TAI-CHUNG TSENG ; Yang W.-T; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 10 | 9 | |
2016 | Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma | Sung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; CHUN-JEN LIU ; PEI-JER CHEN ; Lin S.-M.; MING-WHEI YU | Hepatology | 14 | 13 | |
2001 | Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; Cheng Y.-M.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 0 | 2 | |
2016 | Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen | Zhang T.-Y.; Yuan Q.; Zhao J.-H.; Zhang Y.-L.; Yuan L.-Z.; Lan Y.; Lo Y.-C.; Sun C.-P.; Wu C.-R.; Zhang J.-F.; Zhang Y.; Cao J.-L.; Guo X.-R.; Liu X.; Mo X.-B.; Luo W.-X.; Cheng T.; Chen Y.-X.; Tao M.-H.; Shih J.W.K.; Zhao Q.-J.; Zhang J.; PEI-JER CHEN ; Yuan Y.A.; Xia N.-S. | Gut | 95 | 85 | |
1995 | Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C | PEI-MING YANG ; Hwang L.-H.; Lai M.-Y.; Huang W.-L.; Chu Y.-D.; Chi W.-K.; BOR-LUEN CHIANG ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Clinical and Experimental Immunology | 8 | 7 | |
2003 | A prospect for pharmacogenomics in the interferon therapy of chronic viral hepatitis | Shiou-Hwei Yeh ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Antimicrobial Chemotherapy | 5 | 5 | |
2006 | Prospect of individualized medicine in chronic hepatitis C therapy by pharmacogenomics | Hwang Y.; Su C.; Chen D.-S.; PEI-JER CHEN | Current Pharmacogenomics | 3 | 0 | |
2008 | Prospective mutation screening of three common deafness genes in a large Taiwanese cohort with idiopathic bilateral sensorineural hearing impairment reveals a difference in the results between families from hospitals and those from rehabilitation facilities | Chen-Chi Wu ; PEI-JER CHEN ; Chiu Y.-H.; Lu Y.-C.; Wu M.-C.; Hsu C.-J. | Audiology and Neurotology | 33 | 33 | |
2003 | A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; Chang C.-F.; Wu H.-L.; Shau W.-Y.; DING-SHINN CHEN | Gastroenterology | 58 | 54 | |
1996 | A prospective study of transfusion-transmitted GB virus C infection: Similar frequency but different clinical presentation compared with hepatitis C virus | JIN-TOWN WANG ; FENG-CHIAO TSAI ; Lee, Cha-Ze ; PEI-JER CHEN ; JIN-CHUAN SHEU ; Wang T.-H.; DING-SHINN CHEN | Blood | 171 | 159 | |
1999 | Protamine enhances the efficiency of liposome-mediated gene transfer in a cultured human hepatoma cell line | YEN-HSUAN NI ; HONG-YUAN HSU ; PEI-JER CHEN ; MEI-HWEI CHANG | Journal of the Formosan Medical Association | 10 | 8 | |
2022 | Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma | Wang, Sung-Yin; TUNG-HUNG SU ; BANG-BIN CHEN ; CHUN-JEN LIU ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 4 | 4 | |
2004 | Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis | Shiou-Hwei Yeh ; Tsai C.-Y.; JIA-HORNG KAO ; CHUN-JEN LIU ; Kuo T.-J.; Lin M.-W.; Huang W.-L.; Lu S.-F.; Jih J.; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Hepatology | 193 | 182 | |
2018 | Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection | HUNG-CHIH YANG ; Tsou H.-H; Pei S.-N; Chang C.-S; Chen J.-H; MING YAO ; Lin S.-J; Lin J; Yuan Q; Xia N; Liu T.-W; PEI-JER CHEN ; ANN-LII CHENG ; CHIUN HSU ; Taiwan Cooperative Oncology Group | Journal of Hepatology | 69 | 58 | |
2013 | Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients | Yuan Q.; Song L.-W.; CHUN-JEN LIU ; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Gut | 67 | 63 | |
2015 | Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection | Song L.-W.; Liu P.-G; CHUN-JEN LIU ; Zhang T.-Y; Cheng X.-D; Wu H.-L; HUNG-CHIH YANG ; Hao X.-K; Yuan Q; Zhang J; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Clinical Microbiology and Infection | 98 | 86 | |
1995 | Quasispecies of hepatitis c virus and genetic drift of the hypervariable region in chronic type c hepatitis | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Wang T.-H.; Chen D.-S. | Journal of Infectious Diseases | 47 | 42 |